// App-Quantinova.ai

: Management of 1,25-dihydroxyvitamin D (1,25-OHD) Mediated Hypercalcemia of Unknown Etiology

Researchers

Presenter

  • Sruthi Menon

Principal Investigators

  • Swashti Agarwal

  • David L Paul

Medical Centers

  • Baylor College of Medicine/Texas Children's Hospital, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

  • Autoimmune (AI)

  • Endocrine/metabolic Diseases (ME)

  • Nephrology

Disease

  • Common variable immunodeficiency

  • Hypogammaglobulinaemia

  • Hypercalcaemia

  • Acute renal failure

  • Sarcoidosis

Biomarkers

  • Parathyroid Hormone

Drug/Treatment

  • Hydroxychloroquine

  • Zoledronic acid

  • Ketoconazole

  • Angiotensin II

  • Calcitonin

  • furosemide GR

  • Ergocalciferol

  • Denosumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved